Publication | Closed Access
Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial
76
Citations
23
References
2022
Year
MedicineMetronomic TherapyP16ink4a-deficient MesotheliomaPathologyCancer TreatmentOncologyRadiation OncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1